GERTRUDE OG JACK NELSONS FOND FOR STUDIER INNEN KLINISK FARMAKOLOGI

Share Ownership

Return on Equity

−16,36 %

Current Ratio

N/A

Debt-to-Equity Ratio

Key figures (NOK)	2022	2021	2020	2019
Revenue	−506 000	580 000	488 000	693 000
Net Income	−629 000	458 000	364 000	582 000
Total Assets	3 844 000	4 543 000	4 015 000	3 651 000
Total Equity	3 844 000	4 473 000	4 015 000	3 651 000

Income (NOK)	2022	2021	2020	2019
Revenue	−506 000	580 000	488 000	693 000
Expenditure	19 000	19 000	19 000	21 000
Operating Profit	−524 000	561 000	469 000	672 000
Financial Income	0	0	0	0
Financial Costs	105 000	103 000	105 000	90 000
Financial Balance	−105 000	−103 000	−105 000	−90 000
Earnings Before Tax	−629 000	458 000	364 000	582 000
Tax	0	0	0	0
Net Income	−629 000	458 000	364 000	582 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	0	0	0	0
Total Current Assets	3 844 000	4 543 000	4 015 000	3 651 000
Total Assets	3 844 000	4 543 000	4 015 000	3 651 000
Total Retained Equity	1 529 000	2 159 000	1 792 000	1 501 000
Total Equity	3 844 000	4 473 000	4 015 000	3 651 000
Total Long-Term Debt	0	0	0	0
Total Current Debt	0	70 000	0	0
Total Equity and Debt	3 844 000	4 543 000	4 015 000	3 651 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	0	0	0	0
Other Income	−506 000	580 000	488 000	693 000
Revenue	−506 000	580 000	488 000	693 000
Cost of Goods Sold	0	0	0	0
Salary Costs	14 000	14 000	14 000	16 000
Depreciation	0	0	0	0
Impairment	0	0	0	0
Expenditure	19 000	19 000	19 000	21 000
Operating Profit	−524 000	561 000	469 000	672 000
Financial Income	0	0	0	0
Financial Costs	105 000	103 000	105 000	90 000
Financial Balance	−105 000	−103 000	−105 000	−90 000
Dividends	0	0	0	0
Net Income	−629 000	458 000	364 000	582 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	0	0	0	0
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	0	0	0	0
Total Tangible Assets	0	0	0	0
Total Fiancial Fixed Assets	0	0	0	0
Total Fixed Assets	0	0	0	0
Stock	0	0	0	0
Total Investments	3 715 000	4 348 000	3 832 000	3 498 000
Cash, Bank	128 000	195 000	183 000	154 000
Total Current Assets	3 844 000	4 543 000	4 015 000	3 651 000
Total Assets	3 844 000	4 543 000	4 015 000	3 651 000
Total Equity	3 844 000	4 473 000	4 015 000	3 651 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	0	0	0	0
Creditors	0	0	0	0
Unpaid Taxes	0	0	0	0
Dividends	0	0	0	0
Other Current Debt	0	70 000	0	0
Total Current Debt	0	70 000	0	0
Total Equity and Debt	3 844 000	4 543 000	4 015 000	3 651 000

Financial indicators	2022	2021	2020	2019
Return on Equity	−16,36 %	10,24 %	9,07 %	15,94 %
Debt-to-Equity Ratio	0	0	0	0
Operating Profit Margin	103,56 %	96,72 %	96,11 %	96,97 %
Current Ratio	-	64,9	-	-
Quick Ratio	-	64,9	-	-
Equity Ratio	1	0,98	1	1
Gross Profit Margin	100 %	100 %	100 %	100 %